Although video polysomnography (vPSG) is not routinely recommended for the evaluation of typical cases of non-rapid eye movement (NREM) parasomnias, it can aid diagnosis of unusual cases, other sleep disorders and complicated cases with REM behaviour disorder (RBD), and in differentiating parasomnias from epilepsy. In this study, we aimed to assess vPSG findings in consecutive patients with a clinical diagnosis of NREM-parasomnia covering the whole phenotypic spectrum. Five hundred and twelve patients with a final diagnosis of NREM parasomnia who had undergone vPSG were retrospectively identified. vPSGs were analysed for features of NREM parasomnia and for the presence of other sleep disorders. Two hundred and six (40.0%) patients were clinically diagnosed with sleepwalking, 72 (14.1%) with sleep terrors, 39 (7.6%) with confusional arousals, 15 (2.9%) with sexsomnia, seven (1.4%) with sleep-related eating disorder, 122 (23.8%) with mixed phenotype, and 51 (10.0%) with parasomnia overlap disorder (POD). The vPSG supported the diagnosis of NREM parasomnia in 64.4% of the patients and of POD in 98%. In 28.9% of the patients, obstructive sleep apnea (OSA) or/and periodic limb movements during sleep (PLMS) were identified, most commonly in older, male, sleepy and obese patients. vPSG has a high diagnostic yield in patients with NREM parasomnia and should be routinely performed when there is diagnostic doubt, or in patients where there is a suspicion of OSA and PLMS.
epilepsy is suspected. (Bisulli et al., 2011; Derry et al., 2006; Fois, Wright, Sechi, Walker, & Eriksson, 2015; Zucconi et al., 1997) . They may also reveal features suggestive of NREM parasomnia, such as abrupt arousals from NREM3 sleep, or may confirm the diagnosis by capturing relevant behaviours arising from NREM3 (Aldrich & Jahnke, 1991; Blatt, Peled, Gadoth, & Lavie, 1991; Fois et al., 2015; Kavey, Whyte, Resor, Jr, & Gidro-Frank, 1990 ).
The current American Academy of Sleep Medicine (AASM) guidelines on the use of vPSG in parasomnia suggest that it be reserved for patients with violent or potentially injurious behaviours, cases where there is a failure to respond to therapy, or cases with an atypical or forensic presentation (Kapur et al., 2017) . These guidelines do not comment on the identification of concomitant sleep pathology in patients with parasomnia, such as obstructive sleep apnea (OSA) and periodic limb movements during sleep (PLMS). Identifying these may be meaningful as they may serve as precipitating factors for NREM parasomnia behaviours, facilitating different approaches to the treatment of parasomnia patients (Fois et al., 2015; Guilleminault et al., 2005) .
Our current understanding of sleep and sleep pathology in NREM parasomnia is mainly based on relatively small case series (Brion et al., 2012; Espa, Dauvilliers, Ondze, Billiard, & Besset, 2002; Guilleminault et al., 2005; Guilleminault, Moscovitch, Yuen, & Poyares, 2002) , observational studies with polysomnographic recordings (Fois et al., 2015; Guilleminault, Palombini, Pelayo, & Chervin, 2003) , and epidemiological studies that did not involve polysomnographic assessment of the patients (Ohayon, Mahowald, Dauvilliers, Krystal, & Leger, 2012) . Many of the studies published to date have focused on individual NREM parasomnia phenotypes. Similarly, relatively little is known about vPSG findings in patients with parasomnia overlap disorder (POD), wherein NREM parasomnia and REM behaviour disorder (RBD) coexist, something reported in up to 28% of patients with sleepwalking or sleep terrors (Schenck & Howell, 2013; Schenck, Boyd, & Mahowald, 1997) .
The aim of this study was to assess the findings of vPSG performed in a large cohort of patients with a diagnosis of NREM parasomnia with or without coexisting RBD. We aimed to evaluate the diagnostic utility of vPSG both in NREM parasomnia and POD, particularly in the identification of other sleep disorders that may serve as precipitants of parasomnia behaviours.
| MATERIALS AND METHODS

| Patient selection
Using an internal sleep laboratory database, we retrospectively identified adult patients with a final diagnosis of NREM parasomnia, fol- 
| Sleep study methodology
Inpatient vPSG was performed using a standard 10-20 EEG montage for all patients, with sleep stages scored according to the standard criteria of the AASM. Extended montage EEG with additional leads (17 versus 6 for standard montage) was applied to patients with a clinical suspicion of epilepsy. Continuous recordings included F I G U R E 1 Flow diagram of the studied cohort. Percentages express the prevalence of each diagnostic group within the cohort of 512 patients. vPSG, video polysomnography; SRED, sleep-related eating disorder; Mixed, mixed phenotypes of NREM parasomnia; NREM, non-rapid eye movement sleep; POD, parasomnia overlap disorder electrooculography, electrocardiography, submental and leg electromyography, pulse oximetry, nasal pressure cannulae and respiratory inductance plethysmography, with chest and abdominal belts (Berry et al., 2015) . Time-synchronized video recordings were also performed, while a multidirectional microphone placed above the bed captured audio recordings. In patients requiring multiple sleep latency testing for diagnostic purposes of concomitant sleep disorders, standard guidelines were applied (Carskadon et al., 1986) . 
| Priming and precipitating factors
Medical records were searched for priming factors associated with NREM parasomnia, including sleep deprivation, stress, insomnia, hyperthyroidism, migraines, history of head injury, encephalitis and stroke, and drugs including lithium, phenothiazines, anticholinergic agents, hypnotic drugs and sodium oxybate. Sleep deprivation was captured through sleep dairies or actigraphy, and stress was recorded based on subjects' reports. The diagnosis of insomnia was made based on the existing ICSD criteria at the time of the diagnosis.
Potential precipitating factors, including external stimuli such as noise, light and bed partner's movement, and internal stimuli such as OSA and PLMS, were extracted from patients' notes and vPSG. Patients diagnosed with POD were the oldest among the groups.
| Statistical analysis
There was a male predominance in the sexsomnia group, whereas females predominated in the sleep terror and SRED groups. No differences in BMI and ESS scores were identified between phenotypes (Table 2) . In 35.9% of the patients, a priming factor was identified. The most common of these was stress (52.1%), followed by sleep depri- 
| Polysomnography results
No significant differences between phenotypes were observed in the vPSG sleep macrostructure (Table 3) . At least one precipitating factor was identified on vPSG in 28.9% of patients ( of the patients were receiving medications that could affect the diagnostic yield of the vPSG, including 31/512 (6%) on serotonin reuptake inhibitors, two (0.3%) on serotonin-norepinephrine reuptake inhibitors, 13 (2.5%) on tricyclic antidepressants, three (0.5%) on benzodiazepines and two (0.3%) on zaleplon (Fois et al., 2015) . For example, in a cohort of 124 patients with NREM parasomnia, 21% had sleep-disrupting pathology seen on vPSG (Fois et al., 2015) , and a study of 50 sleepwalkers undergoing polysomnography found an AHI >5 events/hr in 24% (Guilleminault et al., 2005) . At a population level, a diagnosis of OSA appears to confirm a nearly four-fold increase in the likelihood of frequent sleepwalking (Ohayon et al., 2012 Notes. Mixed, mixed phenotypes of NREM parasomnia; SRED, sleep-related eating disorder; POD, parasomnia overlap disorder; OSA, obstructive sleep apnea; PLMS, periodic limb movements during sleep; NT1, narcolepsy type 1; NT2, narcolepsy type 2; IH, idiopathic hypersomnia; vPSG, videopolysomnography; NREM, non-rapid eye movement; NREM-A, spontaneous arousals from NREM3 with typical parasomnia behaviours; NREM-a, spontaneous arousals accompanied by more subtle behaviours, such as raising the head, sympathetic activation, such as tachycardia, or rhythmic delta activity on EEG; RWA, REM without atonia; TST, total sleep time; WASO, wake after sleep onset time; SO, sleep onset; SE, sleep efficiency; AI, arousal index; AHI, apnea-hypopnea index; PLMI, periodic limb movement index. Independent samples Kruskal-Wallis test with Dunn's multiple comparison test was used for comparison of continuous variables between groups. Chisquared with Cramer's V product was used for association between nominal variables. a Chi-squared with Cramer's V product test.
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| 5 of 8 considered, particularly in older, male, obese or sleepy patients presenting with an apparent NREM parasomnia. This is particularly the case in patients with sexsomnia, confusional arousals and POD, amongst whom there was a prevalence of physical pathology of almost 40% or above (Fois et al., 2015) , and in older more obese patients with subjective daytime sleepiness. However, a direct association between concomitant sleep pathologies and NREM parasomnia-related arousals was not confirmed in our study, with parasomnia behaviours being directly preceded by sleep-disrupting pathology in only a minority of cases.
Up to 28% of patients with sleepwalking or sleep terrors have been reported to present with POD features (Schenck & Howell, 2013; Schenck et al., 1997 ). An updated classification included RBD-SRED and RBD-sexsomnia (AASM; Schenck & Howell, 2013) . Subclinical RBD (RWA) can also coexist with NREM parasomnias (Schenck & Howell, 2013) . RBD is considered a precursor of neurodegenerative diseases; RWA may also be relevant in this regard although more research is required (Boeve, 2010; Boeve et al., 2013; McCarter, St Louis, & Boeve, 2012) . No data exist from observational studies covering the whole clinical spectrum of POD. In our study, 10.7% of the patients had features potentially suggestive of subclinical RBD with NREM parasomnia (incidental findings of RWA on vPSG); we did not classify these patients as having a POD diagnosis. Ultimately, 10% of our cohort of 512 consecutive patients were diagnosed with POD, highlighting a considerable overlap between these parasomnia conditions and pinpointing the importance of high clinical suspicion when assessing these patients in clinical settings. As outlined in the previous paragraph, sharing similarly increased percentages of concomitant sleep-disrupting pathologies between confusional arousals and POD could explain at least partially the prevalence of POD, although further research is required to answer the question of whether there are any other pathophysiological relationships between NREM parasomnias and RBD.
The role of vPSG in NREM parasomnia does not seem to be confined to the simple identification of other sleep disorders. (Aldrich & Jahnke, 1991; Fois et al., 2015) . In the previously mentioned study by Fois et al. (2015) , vPSG provided decisive diagnostic information in 33.9% of patients and was supportive of the diagnosis in a further 26.6%. Nonetheless, the evidence base in this area otherwise remains relatively immature, largely consisting of small case series or case reports (Blatt et al., 1991; Guilleminault et al., 2005; Kavey et al., 1990) .
Although the exact mechanisms behind NREM parasomnias are unknown, it is thought that priming factors that increase the amount of NREM3 sleep, and precipitating factors that increase the number of arousals from deep sleep are required to coexist in a genetically predisposed patient for a parasomnia event to occur (Schenck & Howell, 2013) . Many of these factors were originally derived from case reports and clinical histories, but there is now a growing body of experimental evidence that supports their role in NREM parasomnia (Joncas, Zadra, Paquet, & Montplaisir, 2002; . A possible priming factor was identified in more than one-third of our patients, with stress and sleep deprivation accounting for the majority of these (81.4%). Although the identification of a potential priming factor may offer an attractive potential therapeutic avenue, further prospective interventional studies are needed to investigate the effect of modifying priming factors in NREM parasomnia patients.
| Limitations
This is a retrospective study without a predetermined list of data collection for priming and precipitating factors, and limited data were available on family history and age of onset. Our data on concomitant physical sleep pathology apply to a sleep laboratory cohort and may not be applicable to the general population. We had relatively few cases of pure SRED and sexsomnia, so our data on these patients should be interpreted with caution. The lack of validated methods of diagnosing NREM parasomnia through vPSG questions the importance of abrupt arousals from NREM3 accompanied by more subtle behaviours, such as raising the head, sympathetic activation, such as tachycardia, or rhythmic delta activity on EEG, which are not specific to this disorder; consequently, it may be the case that the real diagnostic yield of performing vPSG in parasomnia patients may be significantly lower than our estimate. Although there are some data to support the notion that treating comorbid sleep pathology in parasomnia patients can improve control of parasomnia events (Drakatos et al., 2018; Guilleminault et al., 2005) , it may be the case that the OSA and PLMS identified in this cohort are coincident phenomena rather than precipitating factors. Only a small minority of parasomnia events within our cohort were immediately preceded by either sleep-disordered breathing or PLMS; a prospective study with more rigorous attention given to relationships between sleep-disrupting pathology and parasomnia events could yield a stronger relationship. Finally, although we attempted to adjust our statistical analyses appropriately, we cannot discount the possibility that any apparently significant relationships we identified were type 1 errors contributed to by multiple comparisons.
| CONCLUSION
vPSG has a high diagnostic yield in patients with NREM parasomnia and can aid diagnosis in unusual cases and cases complicated with RBD, and in differentiation from epilepsy. Clinicians should have a high clinical suspicion for physical sleep-disrupting pathology in cases of NREM parasomnia, particularly older, male, obese and sleepy patients.
CONF LICT OF I NTEREST
None of the authors have any relevant conflicts of interest to declare. 
AUTHOR CONTRIBU TI ONS
